integrating-network-pharmacology-to-investigate-cinnamaldehyde-s

Integrating Network Pharmacology to Investigate Cinnamaldehyde's Protective Effect Against Oxaliplatin-induced Neurotoxicity

This study investigates the protective effects of cinnamaldehyde (CA) against oxaliplatin (OXA)-induced damage in rat dorsal root ganglion (DRG) cells. ...

trpa1-chemotherapy-induced-peripheral-neuropathy-promising-target-for

TRPA1 in Chemotherapy-Induced Peripheral Neuropathy: A Promising Target for Immunomodulation and Anti-Inflammatory Therapy

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and serious clinical condition that results when a chemotherapeutic agent damages the ...

China Medical University

Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute

Infrared thermography technology is a diagnostic imaging modality that converts temperature information on the surface of the human body into visualised thermograms. This technology has the capacity to intuitively detect the presence of certain abnormal conditions or foci in the human body. In recent years, the application of this technology in medicine has become increasingly extensive, especially in the areas of auxiliary diagnosis and early screening of diseases.

Infrared thermography in clinical practice: a literature review.

Cisplatin chemotherapy has been used as the main treatment for different types of cancer. However, cisplatin chemotherapy-induced peripheral neuropathic pain (CIPNP) seriously affects the treatment process and quality of life of patients. In addition, it impacts the underlying mechanism and prevention and treatment strategies, indicating that drug selection and efficacy evaluation need to be further investigated. Furthermore, an animal model that is more consistent with the pathological mechanism needs to be developed. In this study, we describe and discuss the methods of developing and detecting CIPNP models in rats and mice induced by cisplatin chemotherapy. The aim was to improve the modeling rate and develop animal models that are more consistent with the developmental pattern of the disease. In addition, the study provides ideal reference animal models for clinical research and drug discovery and development.

Animal models of cisplatin-induced neuropathic pain.

The incidence and mortality rates of digestive tract tumors, especially gastric and colorectal cancers, are high worldwide. Owing to their unique advantages, such as efficient drug loading, safety, and targeting properties, nanoparticles (NPs) have demonstrated great potential in the treatment of gastrointestinal tumors. However, their practical application is limited by several factors, such as high costs, few clinical trials, and long approval periods. In this review, we summarize three types of immunotherapeutic nanomaterial drugs for gastrointestinal tumors: organic, inorganic, and hybrid nanomaterials. This article also discusses the current status of research and development in this field and the advantages of each type of material to provide theoretical references for developing new drugs and advancing clinical research.

Nanomaterials for targeted drug delivery for immunotherapy of digestive tract tumors.

Oxaliplatin, a third-generation platinum-based chemotherapeutic agent, has shown substantial efficacy in cancer treatment. However, its associated side effects, particularly chemotherapy-induced peripheral neuropathic pain (CIPNP), continue to challenge cancer survivors globally. Clinically, it frequently presents as numbness, coldness, and discomfort in the limbs and extremities. Duloxetine is advised for analgesic purposes. Despite its clinical relevance, both the application methods and the underlying mechanisms of oxaliplatin-induced CINP warrant further investigation. Consequently, more precise animal models are needed to explore the mechanisms and progression of this condition. This review consolidates recent advancements in rat and mouse models of oxaliplatin-induced CINP, with the aim of enhancing modeling success rates and developing models that more accurately mirror disease progression. Such models are essential for advancing clinical research and drug development.

Oxaliplatin-induced neuropathic pain in cancer: animal models and related research progress.

The complexity of the tumor immune microenvironment (TIME), which is composed of mainly tumor cells, immune cells, and cytokines, is a major obstacle limiting the effectiveness of immunotherapy, and the interactions among these factors in the TIME determine the efficacy of antitumor immunity. Over the past few years, nanomaterials, owing to their unique physicochemical properties, multifunctionality, and good targeting ability, have gradually become important tools for modulating the immune microenvironment. By precisely delivering immunomodulatory factors, nanomaterials can effectively activate dendritic cells (DCs), enhance the function of effector T cells, and reverse the immunosuppressive state of tumor-associated macrophages (TAMs). In addition, nanomaterials can alleviate the local hypoxic and acidic tumor microenvironment, which in turn promotes immune cell function and enhances the antitumor immune effect. In light of the aforementioned associations, we summarize the existing studies, systematically describe the latest research progress on the use of nanomaterials in regulating the tumor immune microenvironment, and analyze the potential applications and challenges in tumor immunotherapy, with the goal of providing new therapeutic directions and strategies for tumor immunotherapy.

Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy.

The intestinal microbiota, present in vast numbers within the human body, plays a pivotal role, with its composition and abundance varying significantly across individuals. This gut microbiota not only contributes to normal physiological development but also impacts the initiation, progression, resolution, and prognosis of various diseases. Recent studies have increasingly illuminated the connection between intestinal microbiota and pain, with a particular focus on the relationship between gut microbiota and neuropathic pain (NP). NP, an acute and chronic pain disorder arising from sensory nervous system injury, encompasses both peripheral and central neuropathic pain. Evidence suggests that intestinal microbiota influences NP occurrence and may modulate its severity. This review synthesizes current research findings on the microbiota-NP relationship, aiming to establish a theoretical foundation for future clinical investigations.

Advances in the Study of Intestinal Microbiota and Neuropathic Pain.

Peripheral Nerve Injury (PNI) is a common condition in modern clinical practice, characterized by a high incidence and significant debilitating consequences. This narrative review systematically delineates the dual functions of key pro-inflammatory (e.g., IL-1β, IL-6, IL-17) and anti-inflammatory (e.g., IL-4, IL-10, IL-13) interleukins in the spatiotemporal context of nerve injury. This is a narrative review, the review systematically summarizes the dual pro-inflammatory and anti-inflammatory roles of interleukins in peripheral nerve injury. The therapeutic potential of interleukin-based treatment strategies, including inhibitors, agonists, and their combined applications with cell therapy, gene therapy, physical therapy, etc., was explored, and the limitations of current research and future research directions were pointed out. By synthesizing current evidence, this review aims to provide a comprehensive mechanistic overview and highlight emerging interleukin-centric therapeutic paradigms for PNI.

The role of interleukins in peripheral nerve injury and the current status of treatment.

Chemotherapy-induced neuropathic pain (CINP) is a frequent side effect of chemotherapy, and the mechanisms by which Huangqi Guizhi Wuwu Tang (HQGZWWT) prevents and treats CINP remain to be further elucidated.

ArticleTotal : 2	Year
Publication title Cited by 1	2025
Publication title	2026

Article	Year
Infrared thermography in clinical practice: a literature review. European journal of medical research\| PubMed ID: 39815375	2025
Animal models of cisplatin-induced neuropathic pain. Animal models and experimental medicine\| PubMed ID: 39854055	2025
Nanomaterials for targeted drug delivery for immunotherapy of digestive tract tumors. Frontiers in immunology\| PubMed ID: 40109337	2025
Oxaliplatin-induced neuropathic pain in cancer: animal models and related research progress. Frontiers in pharmacology\| PubMed ID: 40520182	2025
Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy. Frontiers in immunology\| PubMed ID: 40672947	2025
Advances in the Study of Intestinal Microbiota and Neuropathic Pain. Frontiers in bioscience (Landmark edition)\| PubMed ID: 41351422	2025
The role of interleukins in peripheral nerve injury and the current status of treatment. Frontiers in immunology\| PubMed ID: 41573554	2025
A study on the network pharmacology of HQGZWWT that prevents CINP by inhibiting ferroptosis through regulation of the p38/c-FOS/NF-kB pathway. Journal of ethnopharmacology\| PubMed ID: 41619865	2026

Huini Yao

Biography

JoVE Journal Publications

Other Publications